The Technical Analyst
Qilian International [QLI]
Exchange: NASDAQ Global Market Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
Qilian International Price, Forecast, Insider, Ratings, Fundamentals & Signals
11.39% $0.789
/ 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 28.21 mill |
| EPS: | -0.220 |
| P/E: | -3.59 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 35.75 mill |
| Avg Daily Volume: | 0.166 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 3/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | n/a | |||||
| Asset | n/a | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.59 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -3.59 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.398 (-49.55%) $-0.391 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.703 - 0.875 ( +/- 10.90%) |
| ATR Model: 14 days |
Forecast:
16:00 - $0.789
Live Trading Signals (every 1 min)
Forecast
1: 14:55 - $0.806
Forecast 2: 15:45 - $0.790
Forecast 3: 16:00 - $0.789
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.789 (11.39% ) |
| Volume | 0.0019 mill |
| Avg. Vol. | 0.166 mill |
| % of Avg. Vol | 1.168 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For QLI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
QLI
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
Latest Press Releases
2024-01-12 07:30:00 - Press Release
Qilian International Holding Group Receives 180-day Extension From Nasdaq To Meet Minimum Bid Price Rule
Jiuquan, china, jan. 12, 2024 /prnewswire/ -- qilian international holding group limited (nasdaq: qli ) ("qilian" or the "company"), a china-based pharmaceutical and chemical products manufacturer, today announced that on january 10, 2024, the company received a written notification from the nasdaq's listing qualifications department, granting the company another 180 calendar days extension, or until july 8, 2024, to regain compliance with nasdaq's minimum bid price requirement. the company can cure this deficiency if the closing bid price of its ordinary shares is $1.00 per share or higher for at least 10 consecutive business days during this second compliance period.
2023-07-17 10:30:00 - Press Release
Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Jiuquan, china , july 17, 2023 /prnewswire/ -- qilian international holding group ltd (nasdaq: qli) ("qilian" or the "company"), a china-based pharmaceutical and chemical products manufacturer, received notification (the "notification letter") from the nasdaq stock market llc ("nasdaq"), dated july 13, 2023, that the company is not in compliance with the minimum bid price requirement set forth in the nasdaq listing rules for continued listing on the nasdaq global market (the "nasdaq global market"). the notification letter is only a notification of deficiency and not a notice of delisting.
2021-09-16 16:10:00 - Press Release
Qilian International Holding Group Limited Reports Financial Results For The First Six Months Of Fiscal Year 2021
Jiuquan, china, sept. 16, 2021 (globe newswire) -- qilian international holding group limited (nasdaq: qli) (the “company”), a china-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fiscal year 2021 ended march 31, 2021.
2021-08-05 16:30:00 - Press Release
Qilian International Holding Group Limited Signs Agreement With District Government, Settling The Project In Local High-tech Zone
Jiuquan, china, aug. 05, 2021 (globe newswire) -- qilian international holding group limited (nasdaq: qli) (the “company”), a china-based pharmaceutical and chemical products manufacturer, today announced that the company, through its prc subsidiary chengdu qilianshan biotechnology co., ltd. (“chengdu qls”), entered into an agreement (the “agreement”) with chongqing tongnan district government (“ctdg”). pursuant to the agreement, the company's new pig by-product processing facility (the “project”) will be located in tongnan high-tech zone. ctdg agrees to provide the company with preferential policies and support funds.
2021-07-09 08:00:00 - Press Release
Qilian International Holding Group Limited Enters Into Investment Agreement For Pig By-product Processing Project In Chongqing
Jiuquan, china, july 09, 2021 (globe newswire) -- qilian international holding group limited (nasdaq: qli) (the “company”), a china-based pharmaceutical and chemical products manufacturer, today announced that the company, through its prc subsidiary chengdu qilianshan biotechnology co., ltd., has entered into an investment agreement (the "agreement") with chongqing jin tong industrial construction investment co. ltd. (“cjt”) on july 5, 2021, for the construction of a pig by-product processing facility (the “project”) in chongqing.
Latest News
2021-09-16 16:10:00 - GlobeNewsWire
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021
Jiuquan, China, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fiscal year 2021 ended March 31, 2021.
2021-08-05 16:30:00 - GlobeNewsWire
Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local High-tech Zone
Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company, through its PRC subsidiary Chengdu Qilianshan Biotechnology Co., Ltd. (“Chengdu QLS”), entered into an agreement (the “Agreement”) with Chongqing Tongnan District Government (“CTDG”). Pursuant to the Agreement, the Company's new pig by-product processing facility (the “Project”) will be located in Tongnan High-tech Zone. CTDG agrees to provide the Company with preferential policies and support funds.
2021-07-09 08:00:00 - GlobeNewsWire
Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing
Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company, through its PRC subsidiary Chengdu Qilianshan Biotechnology Co., Ltd., has entered into an investment agreement (the "Agreement") with Chongqing Jin Tong Industrial Construction Investment Co. Ltd. (“CJT”) on July 5, 2021, for the construction of a pig by-product processing facility (the “Project”) in Chongqing.
2021-03-29 06:06:44 - Pulse2
QLI Stock Price Increased Over 10% Pre-Market: Why It Happened
The stock price of Qilian International Holding Group Ltd (NASDAQ: QLI) increased by over 10% pre-market. This is why it happened.
2021-02-11 16:45:00 - GlobeNewsWire
Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced its financial results for the fiscal year ended September 30, 2020.
2021-02-08 06:00:00 - GlobeNewsWire
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company will complete the first phase expansion of its new organic fertilizer production facility and put it into production in Jiuquan City, Gansu Province by March 2021. The Company expects to triple its organic fertilizer production capacity upon completion of its first phase expansion.
2021-02-06 10:04:49 - Seeking Alpha
U.S. IPO Week Ahead: Bumble's Billion-Dollar Deal Leads A Buzzy 11 IPO Week
2021-01-14 20:00:00 - GlobeNewsWire
Qilian International Holding Group Limited Announces Closing of Initial Public Offering
Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the closing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.